SCHEMBL7780848

SCHEMBL7780848

CC#Cn1cc(-c2ccccc2)c(-c2ccc(S(N)(=O)=O)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.49
CA1 P00915 11/20 0.48
CA2 P00918 11/20 0.48
CA9 Q16790 11/20 0.48
CA12 O43570 10/20 0.48
PTGS1 P23219 4/20 0.44
MT-CO2 P00403 1/20 0.44
LMNA P02545 1/20 0.44
CA3 P07451 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
ADRA2B P18089 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44
ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777652 0.90 CA9 (0.47) PTGS2CA1CA2CA9CA12
SCHEMBL7780383 0.89 PTGS2 (0.50) PTGS2CA1CA2CA9CA12
SCHEMBL7778153 0.89 PTGS2 (0.49) PTGS2CA1CA2CA9CA12
SCHEMBL7780689 0.89 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7772835 0.87 MAPKAPK2 (0.54) PTGS2CA1CA2CA9CA12
SCHEMBL8627787 0.84 F10 (0.38) CA1CA2CA9CA12LMNA
SCHEMBL6746898 0.82 CA9 (0.43) PTGS2CA1CA2CA9CA12
SCHEMBL7773099 0.82 PTGS2 (0.47) PTGS2CA1CA2PTGS1CA5A
SCHEMBL7780904 0.80 PTGS2 (0.55) PTGS2CA1CA2CA9CA12
SCHEMBL7777643 0.79 PTGS2 (0.58) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed